Orthopedic Braces and Support, Casting and Splints Market Size, Share, and Global Forecast 2025-2035

The global Orthopedic Braces and Support, Casting and Splints Market is on a steady growth trajectory, valued at USD 5.62 billion in 2025 and projected to reach USD 9.34 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.2%. This expansion is driven by the rising prevalence of musculoskeletal disorders, an aging global population, and increasing sports-related injuries. The market is further propelled by technological advancements, such as 3D-printed braces and smart supports with motion sensors, which enhance patient comfort and compliance.

Orthopedic braces, supports, casts, and splints are critical medical devices used to stabilize joints, manage fractures, and support recovery from musculoskeletal injuries. These products address conditions like osteoarthritis, rheumatoid arthritis, and ligament injuries, offering non-invasive alternatives to surgery. Innovations in lightweight materials, such as fiberglass and thermoplastics, and the growing adoption of personalized solutions are reshaping the market, particularly in regions with advanced healthcare infrastructure.

For more insights, request a sample of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7602

Market Analysis

The market is driven by the increasing incidence of musculoskeletal disorders, with 1.71 billion people globally affected, including conditions like low back pain, a leading cause of disability in 160 countries. The aging population, projected to reach 1.5 billion people aged 65 and over by 2050, significantly boosts demand, as older adults are prone to osteoporosis and fractures. Sports injuries, with over 3.5 million annually in the U.S. alone, and road accidents, causing 20–50 million non-fatal injuries yearly, further fuel the need for braces, casts, and splints. Technological advancements, such as 3D-printed casts and smart braces with breathable, hypoallergenic materials, improve patient outcomes and compliance. However, challenges include high costs of advanced devices, which limit accessibility in developing regions, and patient discomfort from bulky braces or skin irritation, leading to non-compliance.

Segment Analysis

The market is segmented by product, material, application, and distribution channel. By product, orthopedic braces and supports dominate due to their versatility in managing conditions like osteoarthritis and ligament injuries, with knee braces holding a significant share due to high demand for osteoarthritis care. Casting supplies and equipment, accounting for 43.6% of the market in 2025, lead due to advancements in lightweight materials like fiberglass. Splinting supplies are growing at a CAGR of 6.37%, driven by their flexibility and use in temporary immobilization. By material, metal-based braces hold a 22.6% share for their durability, while thermoplastic-based splints are the fastest-growing segment due to their moldability and lightweight properties.

Country-wise Insights

In the United States, the market is valued at USD 2.07 billion in 2025, with a projected CAGR of 5.0% through 2035, reaching USD 3.36 billion. The U.S. leads due to its advanced healthcare infrastructure, high incidence of osteoporosis (affecting over 10 million people), and 8.6 million annual sports injuries. North America holds a 36.8% global share, driven by robust R&D and companies like DJO Global. In the United Kingdom, the market is expected to grow at a CAGR of 4.8%, reaching USD 400 million by 2035, fueled by demand for knee braces and supportive policies, though GDPR compliance for smart devices poses challenges.

Key Players

  • DJO Global, Inc.
  • Zimmer Biomet Holdings, Inc.
  • 3M Company
  • Ottobock SE & Co. KGaA
  • Breg, Inc.
  • DeRoyal Industries, Inc.
  • Bauerfeind AG
  • Össur hf

Strategic Outlook and Industry Trends

The market is evolving through technological innovation and a focus on patient-centric solutions. The adoption of 3D printing, as seen in the U.S. Army’s FastCast spray foam cast launched in March 2024, enables rapid, customized immobilization. Smart braces with sensors and AI integration are gaining traction for real-time monitoring and improved outcomes. The shift toward non-invasive treatments, particularly among active elderly and athletes, drives demand for braces as alternatives to surgery. Strategic acquisitions, like Colfax’s USD 3.15 billion purchase of DJO Global in 2018, and partnerships, such as Breg’s collaboration with Joint Operations LLP in 2020, expand market reach. Challenges include high costs, patient discomfort, and limited awareness in remote areas. To sustain growth, companies must invest in R&D for affordable, lightweight solutions and expand into emerging markets with growing healthcare access.

Segmentation of Orthopedic Braces and Support, Casting and Splints Market

By Product:

  • Orthopedic Braces & Supports
    • Upper Extremity (Shoulder, Neck, Elbow, Wrist)
    • Lower Extremity (Knee, Ankle, Hip, Spine)
  • Casting Supplies & Equipment
  • Splinting Supplies & Equipment

By Material:

    • Metal-based Braces
    • Fabric-based Braces
    • Thermoplastic-based Splints
    • Others

By Application:

    • Fracture Management
    • Ligament Injury Support
    • Osteoarthritis Aid
    • Post-operative Care
    • Others (e.g., Kyphosis, Scoliosis)

By Distribution Channel:

    • Orthopedic Clinics
    • Hospitals
    • Over-the-Counter
    • E-commerce

By Region:

    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • East Asia
    • South Asia & Pacific
    • Middle East & Africa

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

 

 

Comments

Post a Comment

Popular posts from this blog

Central Venous Catheters (CVCs) Market Size, Growth Opportunities, and Forecast to 2035

The global   Central Venous Catheters (CVCs) Market   is on a steady growth path, valued at USD 1.5 billion in 2025 and projected to reach USD 2.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.0%. This growth is fueled by the rising prevalence of chronic diseases such as cancer and kidney failure, increasing surgical procedures, and advancements in catheter technology. Central venous catheters are critical medical devices used for administering medications, fluids, nutrients, and monitoring hemodynamic status in critical care, oncology, and long-term treatment settings. The market’s expansion is further supported by the growing geriatric population and the increasing demand for minimally invasive procedures. The significance of this market lies in its essential role in modern healthcare, particularly for patients requiring long-term intravenous access. With an estimated 19.3 million new cancer cases globally in 2020 and chronic kidney disease affecting ...
Read more

Venous Procedure Devices Market Size, Share & Growth Outlook to 2035

The global   Venous Procedure Devices Market   is valued at approximately USD 2.2 billion in 2025 and is projected to surpass USD 4.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.4%. This growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in devices such as stents and catheters. The market is critical for addressing vascular conditions like deep vein thrombosis (DVT) and peripheral arterial disease (PAD), which affect millions globally, with the CDC estimating 900,000 annual DVT cases in the U.S. alone. The shift toward less invasive treatments and the growing adoption of advanced diagnostic tools are further propelling market expansion. The significance of this market lies in its role in improving patient outcomes through innovative devices that enable precise diagnostics and treatments. Venous procedure devices, including catheters, stents, and gu...
Read more

Novel Drug Delivery Systems (NDDS) Market Size, Share, Growth, Trends, and Forecast 2025-2035

The global   Novel Drug Delivery Systems (NDDS) Market   is set for substantial growth, valued at USD 89.7 billion in 2025 and projected to reach USD 172.9 billion by 2035, registering a compound annual growth rate (CAGR) of 6.8%. This growth is fueled by the rising demand for targeted, effective, and minimally invasive treatments for chronic diseases, oncology, and personalized medicine. The increasing focus on optimizing drug bioavailability, enhancing patient compliance, and minimizing side effects is revolutionizing drug delivery and formulation. NDDS encompasses advanced platforms such as transdermal patches, inhalers, liposomes, nanoparticles, implantable pumps, and microneedle systems, transforming therapeutic outcomes across various medical fields. The significance of this market lies in its ability to address critical challenges in traditional pharmacotherapy. With chronic diseases like cancer, diabetes, and cardiovascular conditions affecting millions globally—14.1 m...
Read more